Back to search

Article

Beta Adrenergic Signaling as a Therapeutic Target for Autoimmunity

2025-04-09

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> We recently identified a molecular mechanism involving beta-adrenergic 1 and 2 receptors (β1/2) in the development of T H 17 lymphocytes. Pharmacological and genetic inhibition of these receptors in combination, but not separately, impaired the ability of T-lymphocytes to produce proinflammatory interleukin 17A (IL-17A) and instead promoted the production of protective T r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0cbdde44-417e-5a40-89e9-e7d87fffeaf2
DOI
10.1101/2025.04.05.647384
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beta Adrenergic Signaling as a Therapeutic Target for AutoimmunityDOI 10.1101/2025.04.05.647384
Select a neighboring publication to make it the new centre.